With unparalleled proficiency in Chinese radiopharmaceutical regulations and related technical guiding principles, we have successfully completed over 10 radiopharmaceutical registration applications. Our expertise extends to the development of several industry standard guidelines and active participation in the enhancement of national radiopharmaceutical laws and regulations. We have also been instrumental in advocating for the implementation of systems like MAH.
Leveraging both internal and external resources, we offer comprehensive support in formulating registration strategies, facilitating communication and consultations, managing registration submissions, and preparing detailed dossiers. Our commitment ensures a seamless and efficient regulatory process, driving forward the advancement of radiopharmaceuticals.